XML 32 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Equity and Equity Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Equity Compensation Plan Information

Equity Compensation Plan Information as of December 31, 2018.

 

    Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(a)
    Weighted – average
exercise price of
outstanding options,
warrants and rights
(b)
    Number of securities
remaining available
for future issuances
under equity
compensation plans
(excluding securities
reflected in column
(a) (c)
 
Equity Compensation Plans Approved by Security Holders     297     $ 1,350        
Equity Compensation Plans Not Approved by Security Holders                  
Total     297     $ 1,350        

 

Equity Compensation Plan Information as of September 30, 2019.

 

    Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(a)
    Weighted – average
exercise price of
outstanding options,
warrants and rights
(b)
    Number of securities
remaining available
for future issuances
under equity
compensation plans
(excluding securities
reflected in column
(a) (c)
 
Equity Compensation Plans Approved by Security Holders         $     —        
Equity Compensation Plans Not Approved by Security Holders                  
Total         $        

Schedule of Option Activity

A summary of the Company’s stock option as of September 30, 2019, and changes during the nine-month period then ended is presented below:

 

   

Number of

Options

   

Weighted

Average

Exercise Price

 
Options outstanding at December 31, 2018     -     $ -  
Options granted     43,599,998       0.018  
Options exercised            
Options cancelled     (8,304,761 )     0.018  
Options expired     -       -  
Options at end of period     35,295,237     $ 0.018  
Options exercisable at September 30, 2019     14,533,333     $ 0.018  

Schedule of Nonvested Option Activity

At September 30, 2019 the intrinsic value of the options outstanding is $243,337 and options exercisable is $100,280.Changes in the Company’s non-vested options for the nine months ended September 30, 2019 are summarized as follows:

 

   

Nine Months Ended

September 30, 2019

 
   

Number of

Options

   

Weighted

Average

Exercise Price

 
Nonvested options at December 31, 2018     -     $ -  
Granted     43,599,998       0.018  
Vested     (14,533,333 )     0.018  
Cancelled     (8,304,761 )     0.018  
Nonvested options at September 30, 2019     20,761,904     $ 0.018  

Schedule of Option Outstanding and Exercisable

    Options Outstanding     Options Exercisable  
Range of
Exercise Price
  Number Outstanding     Remaining Average Contractual Life (In Years)     Weighted Average Exercise Price     Number Exercisable     Weighted Average Exercise Price  
$0.0123 -$0.012     35,295,237       4.83     $ 0.018       14,533,333     $ 0.018  
Totals     35,295,237       4.83     $ 0.018       14,533,333     $ 0.018  

Schedule of Warrants Activity

A summary of the Company’s warrants as of September 30, 2019, and changes during the nine-month period then ended is presented below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise Price

 
Warrants outstanding at December 31, 2018     6,783,551     $ 0.0115  
Warrants granted     50,000,000       0.01  
Warrants exercised            
Warrants cancelled            
Warrants expired            
Warrants at end of period     56,783,551     $ 0.01  
Warrants exercisable at September 30, 2019     56,783,551     $ 0.01  

Schedule of Warrants Outstanding and Exercisable

    Warrants Outstanding     Warrants Exercisable  

Range of

Exercise Price

  Number Outstanding     Remaining Average Contractual Life (In Years)     Weighted Average Exercise Price     Number Exercisable     Weighted Average Exercise Price  
$0.01 -$0.0115     56,783,551       1.73     $ 0.01       56,783,551     $ 0.01  
Totals     56,783,551       1.73     $ 0.01       56,783,551     $ 0.01